Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
GLE1 encodes an mRNA export mediator essential for nucleocytoplasmic transport. Biallelic loss‐of‐function and splice‐site variants in GLE1 cause lethal congenital contracture syndrome 1 (LCCS1; MONDO:0009670), a severe autosomal recessive motor neuron disease characterized by fetal akinesia, joint contractures, and perinatal lethality.
Clinically, GLE1‐related LCCS1 presents with arthrogryposis multiplex congenita (HP:0002804), respiratory failure (HP:0002878), and often seizures (HP:0001250). The FinMajor splice founder variant (c.432‐10A>G) is highly prevalent in Finland, and novel compound heterozygous splice mutations have been reported in non-Finnish families. Three unrelated families (six probands) with biallelic GLE1 variants have been described, all with consistent autosomal recessive segregation and early lethality ([PMID:27684565]; [PMID:28657126]; [PMID:32537934]).
Inheritance is autosomal recessive. To date, six probands from three families harbor combinations of splice‐site mutations (e.g., c.1243-2A>G), frameshifts, and nonsense variants. The variant spectrum is dominated by premature termination codons and essential splice defects. A recurrent missense allele, c.2051T>C (p.Ile684Thr), demonstrated pathogenicity in a homozygous state in two siblings who survived to 6 months ([PMID:28657126]).
Functional studies support a loss-of-function mechanism. In patient fibroblasts, residual wild-type transcript correlates with extended survival ([PMID:27684565]). In zebrafish, gle1 deficiency recapitulates motor neuron loss, apoptosis of neural precursors, and motor axon arborization defects, all rescued by wild-type human GLE1 but not by the FinMajor mutant ([PMID:22357925]). Structural analyses show that disease alleles disrupt Gle1 oligomerization and mRNA export activity ([PMID:24243016]).
No conflicting reports have emerged to dispute the GLE1–LCCS1 association. Together, genetic segregation across multiple families, a clear recessive inheritance pattern, and convergent functional data establish a "Moderate" clinical validity based on ClinGen criteria.
Key Take-home: Biallelic GLE1 truncating and splice mutations cause autosomal recessive LCCS1 with a predictable neuromuscular phenotype, informing molecular diagnosis and genetic counseling.
Gene–Disease AssociationModerateSix probands across three unrelated families; consistent autosomal recessive segregation; functional concordance Genetic EvidenceModerateSix probands with biallelic loss‐of‐function and splice variants; autosomal recessive inheritance Functional EvidenceModerateZebrafish model and cellular assays demonstrate rescue by wild-type GLE1 and disrupted mRNA export in mutants |